Cristiane de Cassia Bergamaschi
Overview
Explore the profile of Cristiane de Cassia Bergamaschi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
61
Citations
302
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lopes L, Santos D, Silva J, Bergamaschi C, Moura M, Okuyama J, et al.
BMJ Open
. 2024 Sep;
14(9):e084612.
PMID: 39260842
Introduction: When mental disorders go undetected until later stages, they can result in poorer health outcomes for patients. Primary healthcare (PHC) stands as a strategic setting for the early identification...
2.
de Oliveira J, Alves M, Lopes L, Motter F, Iwami R, Bergamaschi C, et al.
BMJ Open
. 2024 Aug;
14(7):e079292.
PMID: 39089716
Objective: There is limited information regarding the incidence of treatment-related adverse events (AE) following antiretroviral therapy (ART) in women. So, this review aimed to describe the incidence of AE of...
3.
Lages L, Bergamaschi C, Lopes L, da Frota E, Silva M, Monte T, et al.
Front Pharmacol
. 2024 Jul;
15:1385401.
PMID: 39076590
Periodontal procedures can promote prolonged intense pain, particularly in clinical situations requiring surgical procedures. In this context, preemptive analgesia has also been assessed for its utility in controlling post-operative pain...
4.
Preemptive use of anti-inflammatories and analgesics in oral surgery: a review of systematic reviews
Pimenta R, Takahashi C, Barberato-Filho S, McClung D, Moraes F, de Souza I, et al.
Front Pharmacol
. 2024 Feb;
14:1303382.
PMID: 38328575
This review of systematic reviews evaluated the effectiveness and safety of the preemptive use of anti-inflammatory and analgesic drugs in the management of postoperative pain, edema, and trismus in oral...
5.
Iwami R, Silva M, Bergamaschi C
Rev Bras Med Trab
. 2024 Feb;
21(2):e2021887.
PMID: 38313079
Introduction: Low back pain and work-related musculoskeletal disorders are two of the leading causes of absenteeism worldwide. Objectives: To determine the prevalence and predictive factors of low back pain and...
6.
Del Fiol F, Bergamaschi C, De Andrade-Jr I, Tolentino da Silva M, Barberato-Filho S, Bellini Silva B, et al.
J Infect Dev Ctries
. 2023 Jul;
17(7):930-936.
PMID: 37515794
Introduction: With the advent of the pandemic in 2020 and the lack of perspectives on the treatment of COVID-19, numerous therapeutic proposals have emerged, including hydroxychloroquine and azithromycin. Therefore, some...
7.
Tavares Franquez R, Moura M, McClung D, Barberato-Filho S, Lopes L, Silva M, et al.
Diabetes Res Clin Pract
. 2023 Jul;
203:110854.
PMID: 37499879
Objective: This systematic review of randomized clinical trials (RCT) summarized the available evidence regarding the use of e-Health technologies for the treatment of depression, anxiety, and emotional distress in person...
8.
Lopes L, de Oliveira J, Bergamaschi C, Fulone I, da Costa Lima E, Abe F, et al.
BMJ Open
. 2023 Jun;
13(6):e069114.
PMID: 37339843
Introduction: Atypical antipsychotics have been studied to treat autism spectrum disorder (ASD). However, like little is known about whether these drugs are effective and safe when compared in controlled and...
9.
Del Fiol F, Bergamaschi C, Lopes L, Silva M, Barberato-Filho S
Front Pharmacol
. 2023 Apr;
14:1131357.
PMID: 37007033
The social restrictions among coronavirus disease 2019 (COVID-19) pandemic have posed a thoughtful risk to mental health and have implications in the use of drugs, including antidepressants, anxiolytics and other...
10.
Tavares Franquez R, de Souza I, Bergamaschi C
PLoS One
. 2023 Feb;
18(2):e0281376.
PMID: 36758047
This review of systematic reviews of randomized clinical trials summarized the available evidence regarding the effectiveness and safety of interventions to treat depression and/or anxiety in people with type 1...